SwePub
Sök i LIBRIS databas

  Extended search

(WFRF:(Abdel Wahab Mohamed A.))
 

Search: (WFRF:(Abdel Wahab Mohamed A.)) > Emergence of Multid...

  • Sid Ahmed, Mazen,1970-Örebro universitet,Institutionen för naturvetenskap och teknik,Microbiology Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar,The Life Science Centre-Biology (author)

Emergence of Multidrug- and Pandrug- Resistant Pseudomonas aeruginosa from Five Hospitals in Qatar

  • Article/chapterEnglish2019

Publisher, publication year, extent ...

  • Elsevier,2019
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:oru-87548
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-87548URI
  • https://doi.org/10.1016/j.infpip.2019.100027DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Funding Agency:Hamad Medical Corporation RGC-01-51-033
  • Background: A global rise in multidrug-resistant (MDR) nosocomial infections has led to a significant increase in morbidity and mortality. MDR Gram-negative bacteria (GNB) are recognised for rapidly developing drug resistance. Despite Pseudomonas aeruginosa being the second most common GNB isolated from healthcare associated infections, the magnitude of MDR P. aeruginosa (MDR-PA) has not been evaluated in Qatar.Aim: To assess the prevalence and antimicrobial susceptibility patterns of MDR-PA from 5major hospitals in Qatar.Methods: A total of 2533P. aeruginosaclinical isolates were collected over a one-year period. MDR-PA was defined as resistance to at least one agent of3 antibiotic classes. Clinical and demographic data were collected prospectively.Findings: The overall prevalence of MDR-PA isolates was 8.1% (205/2533); the majority of isolates were from patients exposed to antibiotics during 90 days prior to isolation (85.4%,177/205), and the infections were mainly hospital-acquired (95.1%, 195/205) with only 4.9% from the community. The majority of MDR-PA isolates were resistant to cefepime (96.6%, 198/205), ciprofloxacin, piperacillin/tazobactam (91%, 186/205), and meropenem (90%, 184/205). Patient comorbidities with MDR-PA were diabetes mellitus (47.3%, n¼97), malignancy (17.1%, n¼35), end-stage renal disease (13.7%, n¼28) and heart failure (10.7%, n¼22).Conclusion: There was a significant prevalence of MDR-PA in Qatar, primarily from healthcare facilities and associated with prior antibiotic treatment. There was an alarming level of antimicrobial resistance to carbapenems. Our results are part of a national surveillance of MDR to establish effective containment plans.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Hassan, A.A.I.Division of General Medicine, Wayne State University, Detroit MI, USA (author)
  • Abu Jarir, S.Departments of Infectious Diseases, Hamad Medical Corporation, Doha, Qatar (author)
  • Abdel Hadi, H.Departments of Infectious Diseases, Hamad Medical Corporation, Doha, Qatar (author)
  • Bansal, D.Communicable Disease Control Programs, Ministry of Public Health, Doha, Qatar (author)
  • Abdul Wahab, A.Departments of Pediatrics, Hamad Medical Corporation, Doha, Qatar; Weill Cornell Medicine-Qatar, Doha, Qatar (author)
  • Muneer, M.Plastic Surgery Department, Hamad Medical Corporation, Doha, Qatar (author)
  • Mohamed, S.F.Hematology Department, Hamad Medical Corporation, Doha, Qatar (author)
  • Zahraldin, K.Departments of Pediatrics, Hamad Medical Corporation, Doha, Qatar (author)
  • Hamid, J.M.Microbiology Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar (author)
  • Alyazidi, M.A.Microbiology Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar (author)
  • Mohamed, M.Department of Pharmacy, Women Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar (author)
  • Sultan, A.A.Department of Microbiology and Immunology, Weill Cornell Medicine-Qatar, Doha, Qatar (author)
  • Söderquist, Bo,1955-Örebro universitet,Institutionen för medicinska vetenskaper(Swepub:oru)bost (author)
  • Ibrahim, E.B.Microbiology Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar; Department of Microbiology and Immunology, Weill Cornell Medicine-Qatar, Doha, Qatar (author)
  • Jass, Jana,1963-Örebro universitet,Institutionen för naturvetenskap och teknik,The Life Science Centre-Biology(Swepub:oru)jjs (author)
  • Örebro universitetInstitutionen för naturvetenskap och teknik (creator_code:org_t)

Related titles

  • In:Infection Prevention in Practice: Elsevier1:3-42590-0889

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view